Lunch Wrap: ASX keeps green streak going as L1 fund goes bargain hunting

The ASX kept grinding higher into lunch as property stocks bounced, and L1 went looking to buy the chaos.

Health Check: Healthcare investors seek earnings clarity from AGM season

The AGM season is upon us, with healthcare investors expecting earnings updates from beaten-down majors including CSL and Cochlear.

First US prescriptions fulfilled for LTR Pharma’s ED treatment ROXUS

The milestone marks the start of ROXUS prescription activity through telehealth and pharmacy arrangements established under LTR Pharma’s agreements with Shed and Strive Pharmacy.

Stakk lands new IBM business for Australia and NZ rollout as digital trust demand builds

The agreement notches another commercial win for Stakk after its recent Candescent and FBI engagements, extending its international business beyond the United States.

Alterity’s biomarker-adjusted Phase 2 analysis shows ~52pc slowing of MSA decline

The analysis also showed that a biomarker of disease severity predicted how quickly patients declined.

StockTake: Copper-gold drilling to begin this month for Artemis